Phase I radioimmunotherapy trial of 131I-huA33 in patients with advanced colorectal carcinoma.

被引：0
|
作者：
Chong, G
Lee, F
Hopkins, W
Mountain, A
Potasz, N
Murphy, R
Chappell, B
Schleyer, P
Papenfus, T
O'Keefe, GJ
Cebon, PUJ
Mitchell, P
Poon, A
Burgess, AW
Hoffman, E
Old, LJ
Scott, AM
机构：
[1] Ludwig Inst Canc Res, Tumour Targeting Program, Melbourne, Vic 3050, Australia
[2] Austin & Repatriat Med Ctr, Ctr PET, Dept Nucl Med, Melbourne, Vic, Australia
[3] Ludwig Inst Canc Res, New York, NY USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2003年 / 44卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
100
引用
收藏
页码：32P / 32P
页数：1
相关论文
共 50 条
  • [1] Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma
    Chong, G
    Lee, F
    Hopkins, W
    Tebbutt, N
    Cebon, JS
    Mountain, AJ
    Chappel, B
    Papenfuss, A
    Schleyer, P
    U, P
    Murphy, R
    Wirth, V
    Smyth, FE
    Potasz, N
    Poon, A
    Davis, ID
    Saunder, T
    O'Keefe, GJ
    Burgess, AW
    Hoffman, EW
    Old, LJ
    Scott, AM
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 4818 - 4826
  • [2] A model of 131I-huA33 pharmacodynamics in patients with colorectal carcinoma.
    Papenfuss, AT
    Chong, G
    Schleyer, PJ
    Chappell, B
    O'Keefe, GJ
    Scott, AM
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 210P - 210P
  • [3] Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of 131I-huA33 with Concurrent Capecitabine
    Herbertson, Rebecca A.
    Tebbutt, Niall C.
    Lee, Fook-Thean
    Gill, Sanjeev
    Chappell, Bridget
    Cavicchiolo, Tina
    Saunder, Tim
    O'Keefe, Graeme J.
    Poon, Aurora
    Lee, Sze Ting
    Murphy, Roger
    Hopkins, Wendie
    Scott, Fiona E.
    Scott, Andrew M.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (04) : 534 - 539
  • [4] Targeted chemoradiation in metastatic colorectal cancer: A Phase I trial of 131I-huA33 with concurrent capecitabine
    Herbertson, R.
    Tebbutt, N.
    Lee, F.
    Gill, S.
    Chapell, B.
    Cavicchiolo, T.
    Saunder, T.
    O'Keefe, G.
    Poon, A.
    Lee, S.
    Murphy, R.
    Hopkins, W.
    Smyth, F.
    Scott, A. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S261 - S261
  • [5] Quantitative intratumoural microdistribution and kinetics of 131I-huA33 antibody in patients with colorectal carcinoma
    Ciprotti, Marika
    Chong, Geoffrey
    Gan, Hui K.
    Chan, Anthony
    Murone, Carmel
    MacGregor, Duncan
    Lee, Fook-Thean
    Johns, Terrance G.
    Heath, Joan K.
    Ernst, Matthias
    Burgess, Antony W.
    Scott, Andrew M.
    EJNMMI RESEARCH, 2014, 4 : 1 - 10
  • [6] Quantitative intratumoural microdistribution and kinetics of 131I-huA33 antibody in patients with colorectal carcinoma
    Marika Ciprotti
    Geoffrey Chong
    Hui K Gan
    Anthony Chan
    Carmel Murone
    Duncan MacGregor
    Fook-Thean Lee
    Terrance G Johns
    Joan K Heath
    Matthias Ernst
    Antony W Burgess
    Andrew M Scott
    EJNMMI Research, 4
  • [7] Targeted chemoradiation for metastatic colorectal cancer: A phase I trial of oral capecitabine combined with 131I-huA33
    Herbertson, R. A.
    Tebbutt, N.
    Gill, S.
    Lee, F. T.
    Chappell, B.
    Cavicchiolo, T.
    Skrinos, E.
    Poon, A.
    Saunder, T.
    Scott, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma
    Sakamoto, Junichi
    Oriuchi, Noboru
    Mochiki, Erito
    Asao, Takayuki
    Scott, Andrew M.
    Hoffman, Eric W.
    Jungbluth, Achim A.
    Matsui, Takanori
    Lee, F. T.
    Papenfuss, Anthony
    Kuwano, Hiroyuki
    Takahashi, Toshitada
    Endo, Keigo
    Old, Lloyd J.
    CANCER SCIENCE, 2006, 97 (11) : 1248 - 1254
  • [9] Phase I/II radioimmunotherapy with I-131 labeled chimeric monoclonal antibody cG250 in patients with metastasized renal cell carcinoma.
    Steffens, MG
    Boerman, OC
    Oosterwijk, E
    Oyen, WJG
    De Mulder, PHM
    Witjes, JA
    Oosterhof, GON
    Debruyne, FMJ
    Corstens, FHM
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 247P - 247P
  • [10] Phase I clinical trial of targeting therapy using 131I-Hepama-1 McAb in patients with hepatocellular carcinoma.
    Chen, SL
    Xie, H
    Wu, JC
    Shi, HC
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 33P - 33P
12345